Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2003
02/06/2003WO2003010308A2 Control of gene expression
02/06/2003WO2003010307A1 Peptide synthase gene, peptide synthase and process for producing dipeptide
02/06/2003WO2003010305A1 Immortilized stem cells
02/06/2003WO2003010303A1 Methods of inducing differentiation of stem cells
02/06/2003WO2003010296A1 K. lactis maltase/maltose permease bi-directional promoter
02/06/2003WO2003010294A2 Genes involved in the biosynthesis of isopentenyl diphosphate in hevea brasiliensis latex
02/06/2003WO2003010293A2 Maize basal layer antimicrobial protein polynucleotides and methods of use
02/06/2003WO2003010290A2 Novel class ii cytokine receptors and uses thereof
02/06/2003WO2003010289A2 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
02/06/2003WO2003010288A2 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
02/06/2003WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
02/06/2003WO2003010284A2 Antisense modulation of c-reactive protein expression
02/06/2003WO2003010283A2 Antisense modulation of pka regulatory subunit rii beta expression
02/06/2003WO2003010282A2 Interleukin-1 beta antibodies
02/06/2003WO2003010243A2 Multipotent stem cells from peripheral tissues and uses thereof
02/06/2003WO2003010204A1 Process for preparation of polypeptides of interest from fusion peolypeptides
02/06/2003WO2003010202A1 Concatameric immunoadhesion
02/06/2003WO2003010201A2 Blood group antigen fusion polypeptides and methods of use thereof
02/06/2003WO2003010200A2 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
02/06/2003WO2003010199A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
02/06/2003WO2003010198A1 Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
02/06/2003WO2003010196A2 Variants and exons of the glyt1 transporter
02/06/2003WO2003010194A2 Meningococcus adhesins nada, app and orf 40
02/06/2003WO2003010193A2 Genes and proteins for the biosynthesis of rosaramicin
02/06/2003WO2003010192A2 An inducer of apoptosis
02/06/2003WO2003010189A1 Process for producing dipeptide, peptide synthase to be used therein and process for producing peptide synthase
02/06/2003WO2003010188A1 Production of high molecular mass lectins
02/06/2003WO2003010187A1 Process for producing dipeptide, l-amino acid amide hydrolase to be used therein and process for producing l-amino acid amide hydrolase
02/06/2003WO2003010186A2 Method for making acylated polypeptides
02/06/2003WO2003010185A2 Method for making acylated polypeptides
02/06/2003WO2003010183A2 Process for preparing variant polynucleotides
02/06/2003WO2003010180A1 Methods and compositions for rnai mediated inhibition of gene expression in mammals
02/06/2003WO2003010176A2 Protein-nucleic acid complexes
02/06/2003WO2003010139A2 Antisense modulation of hormone-sensitive lipase expression
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003WO2003009858A1 Fermentation medium and method
02/06/2003WO2003009816A2 Facile detection of polycythemia vera
02/06/2003WO2003009814A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
02/06/2003WO2003009813A2 Methods of treating neuropilin-mediated diseases
02/06/2003WO2003009808A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
02/06/2003WO2003009806A2 Methods for evaluating pathologic conditions using extracellular rna
02/06/2003WO2003009784A1 Ophthalmic drug delivery device
02/06/2003WO2003009673A1 Transformation of plants by electroporation of cultured explants
02/06/2003WO2002101023A9 A method for altering the isoflavonoid profile in the plant parts of an isoflavonoid-producing plant
02/06/2003WO2002097080A3 Amplification vectors based on trans-splicing
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides
02/06/2003WO2002092772A3 Antisense modulation of ptp1b expression
02/06/2003WO2002090558A9 Novel expression vectors and uses thereof
02/06/2003WO2002086450A3 Compositions and methods for the identification of protein interactions in vertebrate cells
02/06/2003WO2002085337B1 Micellar drug delivery systems for hydrophobic drugs
02/06/2003WO2002079490A3 Bio-barcodes based on oligonucleotide-modified particles
02/06/2003WO2002079245A3 Method for improving plant tolerance to environmental stress
02/06/2003WO2002072849A3 Stress resistance as a selectable marker for transgenic plants
02/06/2003WO2002072805A3 Thymidylate synthase
02/06/2003WO2002068625A3 Packaging cell line for lentiviral vectors
02/06/2003WO2002068467A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002063002A3 Novel human transporter protein and polynucleotides encoding the same
02/06/2003WO2002062848A3 Regulation of cc chemokine receptor 3 (ccr3) expression
02/06/2003WO2002061389A3 Methods to generate and identify monoclonal antibodies to a large number of human antigens
02/06/2003WO2002061126A3 The preparation of polynucleotide arrays
02/06/2003WO2002061110A3 Nucleic acid derivatives
02/06/2003WO2002061034A3 Compositions and methods for rapidly generating recombinant nucleic acid molecules
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002059613A3 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
02/06/2003WO2002046380A3 Protein kinase
02/06/2003WO2002044394A3 Targetet retoviral vectors for cancer immunotherapy
02/06/2003WO2002044355A9 Protozoan expression systems for lysosomal storage disease genes
02/06/2003WO2002042497A3 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids
02/06/2003WO2002042317A3 Method of separating extra-chromosomal dna from other cellular components
02/06/2003WO2002041843A3 Antiinflammation agents
02/06/2003WO2002038045A9 Techniques for deriving tissue structure from multiple projection dual-energy x-ray absorptiometry
02/06/2003WO2002036781A3 Regulation of human glutathione-s-transferase
02/06/2003WO2002032925A9 Protein scaffolds for antibody mimics and other binding proteins
02/06/2003WO2002032291A3 Imaging of enzymatic activity
02/06/2003WO2002031129A3 Human kinases and polynucleotides encoding the same
02/06/2003WO2002030470A9 Methods and compositions for nucleic acid delivery
02/06/2003WO2002028904A3 Human anti-cd40 antibodies
02/06/2003WO2002028900A9 Tach: new tnf-receptor family nucleic acids and polypeptides
02/06/2003WO2002027007A3 Production of viral vectors
02/06/2003WO2002027005A9 Enhanced transfection system
02/06/2003WO2002024879A3 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002020836A3 Method of sequencing dna
02/06/2003WO2002020815A3 Production of cyclic terpenoids
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002018601A3 Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes'
02/06/2003WO2002018577A3 48921, a novel human gtp releasing factor and uses therefor
02/06/2003WO2002018558A3 27439, a human hydroxylase and uses therefor
02/06/2003WO2002016602A3 Compositions and methods for the diagnosis and treatment of tumor
02/06/2003WO2002016592A3 Atcr-1, a human acyltransferase and uses thereof
02/06/2003WO2002016418A3 An iap binding peptide or polypeptide and methods of using the same
02/06/2003WO2002016413A8 Cripto tumour polypeptide
02/06/2003WO2002014490A3 Bacillus transformation, transformants and mutant libraries
02/06/2003WO2002014470A3 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
02/06/2003WO2002012528A3 Enhanced 2-keto-l-gulonic acid production
02/06/2003WO2002012519A3 Counter selection strategy for gram-negative bacteria
02/06/2003WO2002012464A3 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same
1 ... 2597 2598 2599 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 ... 4023